Amphastar Pharmaceuticals (AMPH) Return on Capital Employed Growth (3y) (2017 - 2026)
Amphastar Pharmaceuticals (AMPH) Return on Capital Employed Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 936.60 Mn | 646.48 Mn | 93.47 Mn | -796.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -796.00 |
| Mar 31, 2026 | -1,038.00 |
| Dec 31, 2025 | -738.00 |
| Sep 30, 2025 | -463.00 |
| Jun 30, 2025 | -291.00 |
| Mar 31, 2025 | -13.00 |
| Dec 31, 2024 | 228.00 |
| Sep 30, 2024 | 711.00 |
| Jun 30, 2024 | 1,134.00 |
| Mar 31, 2024 | 1,373.00 |
| Dec 31, 2023 | 1,297.00 |
| Mar 31, 2023 | 1,616.00 |
| Dec 31, 2022 | 1,682.00 |
| Sep 30, 2022 | 1,473.00 |
| Jun 30, 2022 | 1,509.00 |
| Mar 31, 2022 | 1,449.00 |
| Dec 31, 2021 | 1,474.00 |
| Sep 30, 2021 | 1,188.00 |
| Jun 30, 2021 | 993.00 |
| Mar 31, 2021 | 594.00 |